Ithaca, NY, United States of America

Ian Parson

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Parson - Innovator in Antiviral Compounds

Introduction

Ian Parson is a notable inventor based in Ithaca, NY (US). He has made significant contributions to the field of antiviral research, particularly through his innovative work on naphthoquinone compounds. His research focuses on developing novel antiviral agents that can combat viral infections, including HIV.

Latest Patents

Ian Parson holds a patent for "Antiretroviral naphthoquinone compounds compositions and uses thereof." This invention provides novel antiviral naphthoquinone compounds, which may be isolated from plants of the genus Conospermum or synthesized chemically. The compounds, derivatives, and prodrugs may be used alone or in combination with other antiviral agents in pharmaceutical compositions to inhibit the growth or replication of viruses, particularly retroviruses like HIV-1 and HIV-2.

Career Highlights

Ian Parson has dedicated his career to researching antiviral compounds and their applications in medicine. His work has the potential to significantly impact the treatment and prevention of viral infections. He is associated with the United States of America as Represented by the Secretary of, where he continues to advance his research.

Collaborations

Ian has collaborated with notable colleagues, including Lewis K Pannell and Kirk R Gustafson. These collaborations have contributed to the development and refinement of his innovative antiviral compounds.

Conclusion

Ian Parson's work in developing antiviral naphthoquinone compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral infections, particularly HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…